| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |